Alpha 1-antitrypsin deficiency

Chronic Obstructive Pulmonary Disease (COPD) is the result of the obstruction of the airways and of the air out of the lungs as you exhale. Not only is this condition usually permanent with attacks (called exacerbations when the attacks become worse, even life-threatening) occurring over long periods of time (hence the word “chronic” in the name of the condition), it can also become more serious with each attack. COPD is usually caused by three conditions that over time that wreak havoc on the respiratory

Chronic obstructive pulmonary disease (COPD) is a group of gradual, incapacitating respiratory conditions, which include emphysema and chronic bronchitis. It is generally characterized by reduced breathing capacity, airflow restriction in the lungs, a persistent cough, and other various symptoms. COPD is notoriously associated with a history of cigarette smoking and has become the number one contributor to mortality in chronic disease of the lower respiratory tract. It is also defined as a preventable

panlobular emphysema which involves destruction of the whole of the acinus. According to theory, centrolobular is the most common type of emphysema in COPD and is more prominent in the upper zones, while panlobular predominates in patients with alpha-1 antitrypsin deficiency and is more prominent in the lower zones. In relation to patients D.Z. with emphysema, the walls between the tiny air sacs in the lungs are damaged due to long-term cigarette smoking effect on his lungs as evidenced by patient c/o difficulty

Many things are changing at an extremely rapid rate in our society. The new advances in the areas of science and biotechnology are raising many ethical and moral dilemmas for everyone. No one will be left unaffected. Everyone will have to make a decision and take a stand on these issues. I will discuss advancements of genetic screening and testing. The first step to any ethical problem is to understand the topic. It is difficult to formulate accurate ideas without knowledge about the topic, so first

Introduction This thesis is related to the investigation of sequence polymorphism of HBx, an HBV oncogene; among non HCC individuals. Subsequently, a comparison is made between HBx sequences of this study and parallel study (HBx sequences from HCC patients). Finally, impact of this sequential polymorphism has been explored on the structure and function of HBx protein. 1.1. Background Hepatitis B is the inflammation of liver which may be self-limiting or leads to fibrosis, cirrhosis or even liver

Cirrhosis and Related Liver Disorders The liver is the largest gland and second largest organ in the human body. It is also the only internal organ capable of regeneration following injury. Located in the abdominal cavity, this reddish brown organ is divided into lobes of different size and shape. The liver plays a critical role in metabolism, digestion, elimination, and detoxification, among other processes. This organ performs a surprisingly large number of functions that influence virtually

Chronic Obstructive Pulmonary Disease and Patient Teaching NSG3045 Caring For Adults II Eunice D. Jones, RN, MSN South University By By Tiffany L. Brown July 27, 2014 Introduction Chronic obstructive pulmonary disease (COPD) is in the top five principal cause of death in the U.S. The disease is an abnormal inflammatory reaction in the lungs with limited airflow. COPD characteristically arises around the age 35. Smoking continues to be the main source of COPD, but is not the only known root

INTRODUCTION: D.E is a 58-year-old white female who has been living with chronic illness, Chronic obstructive pulmonary disease (COPD), for 6 years. A definitive diagnosis, wasn't made until 2010, four years after the onset of the symptoms. She recalls, having a past medical history of sleep apnea, and chronic bronchitis with frequent admission in the hospital from pneumonia. She reports a past surgical history of an abdominal bilateral tubal ligation at the age of 26 years old. Mrs. D.E. reports

used for respiratory disorders such as chronic asthma, chronic bronchitis and emphysema. It is a serious condition that restricts airflow to the lungs and is not fully reversible. It is a major cause of morbidity and mortality in Australia. More than 1 in 20 Australians over 55 have COPD and is also the fifth leading cause of death. There is also a rate of 1,008 per 100,000 of the population aged 55 and over being hospitalized for the condition. The rates among Aboriginal and Torres Strait Islanders

Dr. James Hardy performed the first human lung transplant in 1963, although the patient only lived 18 days.1 The first successful long-term lung transplant was performed in 1983 in Toronto. Recipients of the first lung transplants were plagued by infection, rejection, and most significantly, bronchial anastomotic dehiscence.2 However with advancements in bronchoscopy, ventilation perfusion screening, echocardiography and radiological imaging, there are other post-surgical complications which have